Long-Term, Observational, Global Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies First published 19/02/2025 Last updated 30/07/2025 EU PAS number:EUPAS1000000478 Study Ongoing